Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Perfect Corp. Reports Unaudited Financial Results for the Three Months Ended March 31, 2026
-
Schouw & Co. share buy-back programme, week 17 2026
-
CoinShares Named Asset Manager of the Year at Inaugural Capital Pioneer Awards
-
Coave Therapeutics to unveil OneAAVTM universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors
-
Helio Nears the Completion of Its Debt Restructuring Program
-
Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline
-
Meta Critical Minerals Signs Option Agreement To Acquire High-Grade U.S. Critical Minerals Project Covering Two Historical Deposits Rich in Zircon, Titanium and Rare Earths
-
Climb Bio, Inc. Announces $110.0 Million Private Placement
-
The Prestigious U.S. Open Polo Championship(R) Final Closes a Record-Breaking American Polo Season, Supported by U.S. Polo Assn. and ESPN
-
Eptura Introduces New Innovations Delivering Real-Time Data Visibility and AI-Powered Workflows to Scale Workplace and Operations Management
-
OPAL Fuels Announces First Quarter 2026 Earnings Release Date and Conference Call
-
First Commonwealth Announces First Quarter 2026 Earnings; Increases Quarterly Dividend
-
ThreatDown Accelerates Channel-First Strategy, Grows Distribution from 1% to 40%
-
Ares Capital Corporation Announces March 31, 2026 Financial Results and Declares Second Quarter 2026 Dividend of $0.48 Per Share
-
ezAccounting Software Simplifies 941 Filing with New Efile Add-On feature for First Quarter Deadlines
-
Silver Rock Capital Partners Raises $4 Billion for Private Credit Capital Solutions Strategy
-
JetBlue Announces First Quarter 2026 Results
-
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
-
Polestar Decouples Growth From Negative Climate Impact: Emissions Per Sold Car Cut by 31% in Five Years
-
Cleveland‑Cliffs Announces Multi-Year Partnership with Palantir to Deploy AI Platform
-
Starboard Delivers Letter to Dynatrace
-
Coforge Recognized as a Leader and Star Performer in Everest Group's Duck Creek Services PEAK Matrix® Assessment 2026
-
Potomac Bank Appoints Brian J. Hester as Vice President, Commercial Relationship Manager
-
BANKFIRST CAPITAL CORPORATION Reports First Quarter 2026 Earnings of $8.39 Million
-
Matternet CEO Andreas Raptopoulos Joins Bloomberg to Discuss London NHS Drone Delivery Launch
-
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
-
VectorY Therapeutics Receives U.K. MHRA Authorization and EMA Approval to Initiate Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People Living with Amyotrophic Lateral Sclerosis (ALS)
-
Surf Air Mobility to Announce First Quarter 2026 Financial Results on May 11, 2026
-
AIRNA to Present New Preclinical Data on RNA-Editing Therapeutic Pipeline at ASGCT Annual Meeting
-
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of
-
Affordability Plays Larger Role in Aftermarket Auto Service, but Convenience Still Drives Business, JD Power Finds
-
Promega Authorizes UBC RNA & Formulation Core to Distribute NanoLuc-Encoding mRNA for LNP and mRNA Delivery Research
-
Insulet to Participate in BofA Securities 2026 Health Care Conference
-
CGI announces new Artificial Intelligence Center of Excellence in Portugal
-
Haleon Launches For the Assist Campaign in Partnership with the U.S. Soccer Federation Featuring Stars Tyler Adams and Crystal Dunn
-
Phillips & Cohen Associates Wins American Business Awards® for AI Implementation of the Year
-
PyroGenesis Announces Appointment of Jean Mayer as Vice-President, Legal Affairs and Corporate Secretary
-
TelevisaUnivision Announces First Quarter 2026 Results
-
Latus Bio to Present New Data at ASGCT 2026 Supporting Investigational Gene Therapy Approaches for Huntington’s Disease and CLN2 Disease
-
Remepy Announces Collaboration with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas
-
Incyte Appoints Suketu (Suky) Upadhyay as Chief Financial Officer
-
Watercress Financial Announces $550 Million Forward Flow Partnership with 26North to Expand Home Improvement Financing and Flexible Payment Options
-
Quantum Lifecycle Partners Launches Canada's Most Advanced Plastics Separation System for Electronics Plastics Recovery
-
Señorita Broadens Portfolio With 1777, the Brand’s First Non-Alcoholic THC Spirit
-
Topgolf's Summer Fun Pass Returns at Lowest Price Ever with More Perks
-
Zilliant Survey: Executives Are Adjusting Prices More Than Ever but Losing Control of the Outcomes
-
ECOVACS Slashes Robot Vacuum Prices Up to 45%, Passing Tariff Savings Directly to U.S. Consumers
-
Fujifilm’s Taisuke Fujita Honored with Prestigious ASGE Crystal Award for Contributions to the Advancement of Endoscopic Care
-
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine
-
Vestis Announces Date for Fiscal Second Quarter 2026 Results Conference Call and Webcast

